Inhibitory pathways in the circular muscle of rat jejunum
Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituita...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 2004-09, Vol.143 (1), p.107-118 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 118 |
---|---|
container_issue | 1 |
container_start_page | 107 |
container_title | British journal of pharmacology |
container_volume | 143 |
creator | Vanneste, Gwen Robberecht, Patrick Lefebvre, Romain A |
description | Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum.
Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M).
NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M).
Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ.
The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence.
EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38.
These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels.
British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918 |
doi_str_mv | 10.1038/sj.bjp.0705918 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1575279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>984049751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</originalsourceid><addsrcrecordid>eNqFkL1PwzAUxC0EglJYGVGExJjyXhzH9oIEFV8SEgwwW67jUEdpUuyEqv89qRpRmJjecL93dzpCzhAmCFRchXIyK5cT4MAkij0ywpRnMaMC98kIAHiMKMQROQ6hBOhFzg7JETIKSSbSEZFP9dzNXNv4dbTU7Xyl1yFyddTObWScN12lfbTogqls1BSR121U2rKru8UJOSh0FezpcMfk_f7ubfoYP788PE1vnmPDGJUxZRnLpUWdFpCnIssZJDkAw1khgWumacqRGmG4RSZ4hiK3hhtTCG21kEDH5Hrru-xmC5sbW7deV2rp3UL7tWq0U3-V2s3VR_OlkHGWcNkbXAwGvvnsbGhV2XS-7jurBDkKmeAmZbKFjG9C8Lb4CUBQm6VVKFW_tBqW7h_Of9fa4cO0PXA5ADoYXRVe18aFHZdhwhPKe45uuZWr7PqfWHX7-phlTNJv3WOXtg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217189210</pqid></control><display><type>article</type><title>Inhibitory pathways in the circular muscle of rat jejunum</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Wiley Free Archive</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Vanneste, Gwen ; Robberecht, Patrick ; Lefebvre, Romain A</creator><creatorcontrib>Vanneste, Gwen ; Robberecht, Patrick ; Lefebvre, Romain A</creatorcontrib><description>Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum.
Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M).
NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M).
Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ.
The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence.
EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38.
These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels.
British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0705918</identifier><identifier>PMID: 15302684</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenosine Triphosphate - pharmacology ; Adenosine Triphosphate - physiology ; Animals ; Apamin - pharmacology ; ATP ; Autonomic Nervous System - drug effects ; Biological and medical sciences ; cGMP ; Cyclic GMP - physiology ; Electric Stimulation ; Isometric Contraction - drug effects ; Jejunal motility ; Jejunum - drug effects ; Jejunum - innervation ; Male ; Medical sciences ; Methacholine Chloride - pharmacology ; Muscarinic Agonists - pharmacology ; Muscle Contraction - drug effects ; Muscle Contraction - physiology ; Muscle, Smooth - drug effects ; Muscle, Smooth - innervation ; NANC ; Nerve Growth Factors - pharmacology ; Nerve Growth Factors - physiology ; Neuropeptides - pharmacology ; Neuropeptides - physiology ; Neurotransmitter Agents - pharmacology ; Neurotransmitter Agents - physiology ; nitric oxide ; Nitric Oxide - pharmacology ; Nitric Oxide - physiology ; PACAP ; Pharmacology. Drug treatments ; Pituitary Adenylate Cyclase-Activating Polypeptide ; Potassium Channels, Calcium-Activated - drug effects ; rat (Wistar–Han) ; Rats ; Rats, Wistar ; SK channels ; Small-Conductance Calcium-Activated Potassium Channels ; Synaptic Transmission - drug effects ; Tetrodotoxin - pharmacology ; Vasoactive Intestinal Peptide - pharmacology ; VIP</subject><ispartof>British journal of pharmacology, 2004-09, Vol.143 (1), p.107-118</ispartof><rights>2004 British Pharmacological Society</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Sep 2004</rights><rights>Copyright 2004, Nature Publishing Group 2004 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</citedby><cites>FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575279/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575279/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16127237$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15302684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vanneste, Gwen</creatorcontrib><creatorcontrib>Robberecht, Patrick</creatorcontrib><creatorcontrib>Lefebvre, Romain A</creatorcontrib><title>Inhibitory pathways in the circular muscle of rat jejunum</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum.
Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M).
NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M).
Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ.
The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence.
EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38.
These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels.
British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918</description><subject>Adenosine Triphosphate - pharmacology</subject><subject>Adenosine Triphosphate - physiology</subject><subject>Animals</subject><subject>Apamin - pharmacology</subject><subject>ATP</subject><subject>Autonomic Nervous System - drug effects</subject><subject>Biological and medical sciences</subject><subject>cGMP</subject><subject>Cyclic GMP - physiology</subject><subject>Electric Stimulation</subject><subject>Isometric Contraction - drug effects</subject><subject>Jejunal motility</subject><subject>Jejunum - drug effects</subject><subject>Jejunum - innervation</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methacholine Chloride - pharmacology</subject><subject>Muscarinic Agonists - pharmacology</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle Contraction - physiology</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - innervation</subject><subject>NANC</subject><subject>Nerve Growth Factors - pharmacology</subject><subject>Nerve Growth Factors - physiology</subject><subject>Neuropeptides - pharmacology</subject><subject>Neuropeptides - physiology</subject><subject>Neurotransmitter Agents - pharmacology</subject><subject>Neurotransmitter Agents - physiology</subject><subject>nitric oxide</subject><subject>Nitric Oxide - pharmacology</subject><subject>Nitric Oxide - physiology</subject><subject>PACAP</subject><subject>Pharmacology. Drug treatments</subject><subject>Pituitary Adenylate Cyclase-Activating Polypeptide</subject><subject>Potassium Channels, Calcium-Activated - drug effects</subject><subject>rat (Wistar–Han)</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>SK channels</subject><subject>Small-Conductance Calcium-Activated Potassium Channels</subject><subject>Synaptic Transmission - drug effects</subject><subject>Tetrodotoxin - pharmacology</subject><subject>Vasoactive Intestinal Peptide - pharmacology</subject><subject>VIP</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkL1PwzAUxC0EglJYGVGExJjyXhzH9oIEFV8SEgwwW67jUEdpUuyEqv89qRpRmJjecL93dzpCzhAmCFRchXIyK5cT4MAkij0ywpRnMaMC98kIAHiMKMQROQ6hBOhFzg7JETIKSSbSEZFP9dzNXNv4dbTU7Xyl1yFyddTObWScN12lfbTogqls1BSR121U2rKru8UJOSh0FezpcMfk_f7ubfoYP788PE1vnmPDGJUxZRnLpUWdFpCnIssZJDkAw1khgWumacqRGmG4RSZ4hiK3hhtTCG21kEDH5Hrru-xmC5sbW7deV2rp3UL7tWq0U3-V2s3VR_OlkHGWcNkbXAwGvvnsbGhV2XS-7jurBDkKmeAmZbKFjG9C8Lb4CUBQm6VVKFW_tBqW7h_Of9fa4cO0PXA5ADoYXRVe18aFHZdhwhPKe45uuZWr7PqfWHX7-phlTNJv3WOXtg</recordid><startdate>200409</startdate><enddate>200409</enddate><creator>Vanneste, Gwen</creator><creator>Robberecht, Patrick</creator><creator>Lefebvre, Romain A</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>200409</creationdate><title>Inhibitory pathways in the circular muscle of rat jejunum</title><author>Vanneste, Gwen ; Robberecht, Patrick ; Lefebvre, Romain A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenosine Triphosphate - pharmacology</topic><topic>Adenosine Triphosphate - physiology</topic><topic>Animals</topic><topic>Apamin - pharmacology</topic><topic>ATP</topic><topic>Autonomic Nervous System - drug effects</topic><topic>Biological and medical sciences</topic><topic>cGMP</topic><topic>Cyclic GMP - physiology</topic><topic>Electric Stimulation</topic><topic>Isometric Contraction - drug effects</topic><topic>Jejunal motility</topic><topic>Jejunum - drug effects</topic><topic>Jejunum - innervation</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methacholine Chloride - pharmacology</topic><topic>Muscarinic Agonists - pharmacology</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle Contraction - physiology</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - innervation</topic><topic>NANC</topic><topic>Nerve Growth Factors - pharmacology</topic><topic>Nerve Growth Factors - physiology</topic><topic>Neuropeptides - pharmacology</topic><topic>Neuropeptides - physiology</topic><topic>Neurotransmitter Agents - pharmacology</topic><topic>Neurotransmitter Agents - physiology</topic><topic>nitric oxide</topic><topic>Nitric Oxide - pharmacology</topic><topic>Nitric Oxide - physiology</topic><topic>PACAP</topic><topic>Pharmacology. Drug treatments</topic><topic>Pituitary Adenylate Cyclase-Activating Polypeptide</topic><topic>Potassium Channels, Calcium-Activated - drug effects</topic><topic>rat (Wistar–Han)</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>SK channels</topic><topic>Small-Conductance Calcium-Activated Potassium Channels</topic><topic>Synaptic Transmission - drug effects</topic><topic>Tetrodotoxin - pharmacology</topic><topic>Vasoactive Intestinal Peptide - pharmacology</topic><topic>VIP</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vanneste, Gwen</creatorcontrib><creatorcontrib>Robberecht, Patrick</creatorcontrib><creatorcontrib>Lefebvre, Romain A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vanneste, Gwen</au><au>Robberecht, Patrick</au><au>Lefebvre, Romain A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory pathways in the circular muscle of rat jejunum</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2004-09</date><risdate>2004</risdate><volume>143</volume><issue>1</issue><spage>107</spage><epage>118</epage><pages>107-118</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum.
Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M).
NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M).
Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ.
The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence.
EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38.
These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels.
British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>15302684</pmid><doi>10.1038/sj.bjp.0705918</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2004-09, Vol.143 (1), p.107-118 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1575279 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE; Wiley Free Archive; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adenosine Triphosphate - pharmacology Adenosine Triphosphate - physiology Animals Apamin - pharmacology ATP Autonomic Nervous System - drug effects Biological and medical sciences cGMP Cyclic GMP - physiology Electric Stimulation Isometric Contraction - drug effects Jejunal motility Jejunum - drug effects Jejunum - innervation Male Medical sciences Methacholine Chloride - pharmacology Muscarinic Agonists - pharmacology Muscle Contraction - drug effects Muscle Contraction - physiology Muscle, Smooth - drug effects Muscle, Smooth - innervation NANC Nerve Growth Factors - pharmacology Nerve Growth Factors - physiology Neuropeptides - pharmacology Neuropeptides - physiology Neurotransmitter Agents - pharmacology Neurotransmitter Agents - physiology nitric oxide Nitric Oxide - pharmacology Nitric Oxide - physiology PACAP Pharmacology. Drug treatments Pituitary Adenylate Cyclase-Activating Polypeptide Potassium Channels, Calcium-Activated - drug effects rat (Wistar–Han) Rats Rats, Wistar SK channels Small-Conductance Calcium-Activated Potassium Channels Synaptic Transmission - drug effects Tetrodotoxin - pharmacology Vasoactive Intestinal Peptide - pharmacology VIP |
title | Inhibitory pathways in the circular muscle of rat jejunum |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A54%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20pathways%20in%20the%20circular%20muscle%20of%20rat%20jejunum&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Vanneste,%20Gwen&rft.date=2004-09&rft.volume=143&rft.issue=1&rft.spage=107&rft.epage=118&rft.pages=107-118&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1038/sj.bjp.0705918&rft_dat=%3Cproquest_pubme%3E984049751%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217189210&rft_id=info:pmid/15302684&rfr_iscdi=true |